TRS 1052 - Annex 2: WHO good manufacturing practices for excipients used in pharmaceutical products
26 April 2024
| Technical document

Overview
This document provides information on GMP that should be implemented to assist manufacturers to produce and control excipients used in pharmaceutical products that will meet their intended specifications, in a consistent manner. Risk assessment may be useful in determining which excipients should be manufactured in accordance with this guideline.WHO Team
Access to Medicines and Health Products (MHP),
Health Product Policy and Standards (HPS),
Norms and Standards for Pharmaceuticals (NSP),
Technical Standards and Specifications (TSS)
Number of pages
30